Literature DB >> 15191783

Atrial remodeling in persistent atrial fibrillation: the potential role of aldosterone.

Panagiotis Korantzopoulos, Theofilos Kolettis, Evaggelos Kountouris, Konstantinos Siogas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15191783     DOI： 10.1016/j.ehj.2003.12.033

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

1.  A beneficial effect of 3-year spironolactone therapy supplementing atenolol therapy on the remodeling of atria and ventricles in a patient with permanent atrial fibrillation.

Authors:  Rafał Dabrowski; Cezary Sosnowski; Ewa Michalak; Hanna Szwed
Journal:  Intern Emerg Med       Date:  2009-02-19       Impact factor: 3.397

Review 2.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

3.  Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.

Authors:  Ricardo Gómez; Lucía Núñez; Ricardo Caballero; Miguel Vaquero; Juan Tamargo; Eva Delpón
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.